B.C Cancer Agency Protocol Summary SCPAINLI Page 1 of 4 Revision Submitted for approval March 31, 2010 BCCA Protocol Summary for Extreme Pain Therapy Using Parenteral Lidocaine is part of a multi-modal protocol designed to provide optimal perioperative care Who? Patients undergoing general anesthesia for the laparoscopic or open colorectal surgery. Purpose To provide perioperative care that: Maximizes perioperative pain control Reduces opiate requirements and opiate adverse events. Can you give lidocaine on a general floor? Yes. Lidocaine infusion for. Kidney stornes are considered one of the most painful conditions to present to the emergency department. Learn more about the benefits of using lidocaine infusion as an intervention for renal colic pain in the emergency department. NURSING CARE STANDARDS PROTOCOL NCS6470 –Lidocaine IV Low dose: Neuropathic / Post-op Pain April 2016 NCS6470 - Page 1 of 10 Published by: Providence Health Care, Vancouver, BC Lidocaine infusions were discontinued upon complete pain relief, experiencing of intolerable side effects, after 30 minutes of infusion, or if requested by patients. We are uncertain whether IV perioperative lidocaine, when compared to placebo or no treatment, has a beneficial impact on pain scores in the early postoperative phase, and on gastrointestinal recovery, postoperative nausea, and opioid consumption. The effect of intraoperative lidocaine administration is sustained beyond its infusion period and continues into the postoperative period. 7 This study confirmed that patients receiving lidocaine had decreased analgesic requirements and pain scores that became more prominent 36 h after the lidocaine infusion had been terminated. Our acute pain management lidocaine infusion protocol uses a 0.5 mg/min starting dose with a maximum of 1 mg/min for adults, and doses between 15 to 25 mcg/kg/min for pediatric patients 40m kg. Approval and Developement of the Acute Pain Management Lidocaine Infusion Protocol at the University of Virginia Background. Administration of intravenous lignocaine infusion is indicated in patients with chronic neuropathic (nerve memory) pain [such as occurs with acute spinal cord injury, polyneuropathy, complex regional pain syndrome, deafferentation or postamputation], central pain syndromes and cancer pain that have not responded to other interventions.